3201 - 3225 of 9034 Results
Title
Year
-
OPENTitle: An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 alleleJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 127Issue #:Start Page: 278End Page: 286Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2019.02.023Best OA location URL: https://doaj.org/article/6a674f9f412742f7840d1c3d8f970659Citation Count: 34
-
OPENTitle: Investigating ELOVL7 coding variants in multiple system atrophyJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 749Issue #:Start Page: 135723End Page: 135723Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2021.135723Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7983070Citation Count: 2
- Correlations between CSF proteins and spontaneous neuronal activity in Parkinson’s disease2018RESTRICTEDTitle: Correlations between CSF proteins and spontaneous neuronal activity in Parkinson’s diseaseJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 673Issue #:Start Page: 61End Page: 66Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2018.02.062Citation Count: 6
-
OPENTitle: TMEM230 in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 56Issue #:Start Page: 212.e1End Page: 212.e3Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2017.03.014Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5526081Citation Count: 9
- Insufficient evidence for pathogenicity of SNCA His50Gln (H50Q) in Parkinson's disease2017RESTRICTEDTitle: Insufficient evidence for pathogenicity of SNCA His50Gln (H50Q) in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 64Issue #:Start Page: 159.e5End Page: 159.e8Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2017.12.012Citation Count: 43
-
OPENTitle: Estimating brain age based on a uniform healthy population with deep learning and structural magnetic resonance imagingJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 91Issue #:Start Page: 15End Page: 25Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.02.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7890463Citation Count: 100
-
OPENTitle: The role of RHOT1 and RHOT2 genetic variation on Parkinson disease risk and onsetJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 97Issue #:Start Page: 144.e1End Page: 144.e3Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.07.003Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7736199Citation Count: 9
- Decision Support for Medication Change of Parkinson's Disease Patients2020RESTRICTEDTitle: Decision Support for Medication Change of Parkinson's Disease PatientsJournal Name: Computer Methods and Programs in BiomedicinePublisher: Elsevier BVVol: 196Issue #:Start Page: 105552End Page: 105552Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cmpb.2020.105552Citation Count: 26
-
OPENTitle: White matter hyperintensities are more highly associated with preclinical Alzheimer's disease than imaging and cognitive markers of neurodegenerationJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 4Issue #: 1Start Page: 18End Page: 27Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.dadm.2016.03.001Best OA location URL: https://doi.org/10.1016/j.dadm.2016.03.001Citation Count: 93
-
OPENTitle: Amnestic mild cognitive impairment individuals with dissimilar pathologic origins show common regional vulnerability in the default mode networkJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 10Issue #: 1Start Page: 717End Page: 725Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.dadm.2018.08.004Best OA location URL: https://doi.org/10.1016/j.dadm.2018.08.004Citation Count: 9
-
OPENTitle: Mental health disparities and the role of perceived discrimination among Latinx individuals living with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 116Issue #:Start Page: 105867End Page: 105867Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105867Best OA location URL: https://doi.org/10.1016/j.parkreldis.2023.105867Citation Count: 6
-
OPENTitle: Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patientsJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 3Issue #:Start Page: 100042End Page: 100042Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2020.100042Best OA location URL: https://doi.org/10.1016/j.prdoa.2020.100042Citation Count: 9
-
OPENTitle: Dopamine genetic risk score predicts impulse control behaviors in Parkinson’s diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 5Issue #:Start Page: 100113End Page: 100113Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2021.100113Best OA location URL: https://doi.org/10.1016/j.prdoa.2021.100113Citation Count: 12
-
OPENTitle: Updated Parkinson's disease motor subtypes classification and correlation to cerebrospinal homovanillic acid and 5-hydroxyindoleacetic acid levelsJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 8Issue #:Start Page: 100187End Page: 100187Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2023.100187Best OA location URL: https://doi.org/10.1016/j.prdoa.2023.100187Citation Count: 21
- Longitudinal hippocampal subfields, CSF biomarkers, and cognition in patients with Parkinson disease2023OPENTitle: Longitudinal hippocampal subfields, CSF biomarkers, and cognition in patients with Parkinson diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 9Issue #:Start Page: 100199End Page: 100199Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2023.100199Best OA location URL: https://doi.org/10.1016/j.prdoa.2023.100199Citation Count: 6
-
RESTRICTEDTitle: Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 14Issue #: 10Start Page: 1002End Page: 1009Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(15)00178-7Best OA location URL: http://doi.org/10.1016/S1474-4422(15)00178-7Citation Count: 224
-
OPENTitle: Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 16Issue #: 1Start Page: 66End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(16)30328-3Best OA location URL: http://doi.org/10.1016/S1474-4422(16)30328-3Citation Count: 427
-
OPENTitle: Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validationJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 16Issue #: 11Start Page: 908End Page: 916Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(17)30328-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5693218Citation Count: 159
-
OPENTitle: Increased striatal dopamine in carriers of GBA mutations: compensation or epiphenomenon?Journal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 27End Page: 29Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30355-2Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6924570Citation Count: 1
-
OPENTitle: Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 71End Page: 80Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30319-9Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/133485Citation Count: 138
- Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial2020RESTRICTEDTitle: Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 7Start Page: 591End Page: 600Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30136-8Citation Count: 143
-
OPENTitle: Developing therapies for Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 10Start Page: 797End Page: 797Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30320-3Best OA location URL: http://www.thelancet.com/article/S1474442220303203/pdfCitation Count: 7
- α-synuclein seed amplification in Parkinson‘s disease2023RESTRICTEDTitle: α-synuclein seed amplification in Parkinson‘s diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 11Start Page: 985End Page: 985Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00373-3Citation Count: 3
- α-synuclein seed amplification in Parkinson's disease – Authors' reply2023OPENTitle: α-synuclein seed amplification in Parkinson's disease – Authors' replyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 11Start Page: 985End Page: 986Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00371-xCitation Count: 7
-
OPENTitle: α-synuclein seed amplification in Parkinson‘s diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 11Start Page: 984End Page: 985Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00374-5Best OA location URL: http://www.thelancet.com/article/S1474442223003745/pdfCitation Count: 3